Cargando…
Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commer...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876484/ https://www.ncbi.nlm.nih.gov/pubmed/33582201 http://dx.doi.org/10.1016/j.jhin.2021.01.031 |
_version_ | 1783649983527911424 |
---|---|
author | Steinhauer, K. Meister, T.L. Todt, D. Krawczyk, A. Paßvogel, L. Becker, B. Paulmann, D. Bischoff, B. Pfaender, S. Brill, F.H.H. Steinmann, E. |
author_facet | Steinhauer, K. Meister, T.L. Todt, D. Krawczyk, A. Paßvogel, L. Becker, B. Paulmann, D. Bischoff, B. Pfaender, S. Brill, F.H.H. Steinmann, E. |
author_sort | Steinhauer, K. |
collection | PubMed |
description | The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commercially available antiseptic mouthwashes based on the active ingredients chlorhexidine digluconate and octenidine dihydrochloride (OCT) were investigated regarding their efficacy against SARS-CoV-2 using the European Standard 14476. Based on the requirement of EN 14476 in which reduction of at least four decimal logarithms (≥4 log(10)) of viral titre is requested to state efficacy, the OCT-based formulation was found to be effective within a contact time of only 15 s against SARS-CoV-2. Based on this in-vitro data the OCT mouthwash thus constitutes an interesting candidate for future clinical studies to prove its effectiveness in a potential prevention of SARS-CoV-2 transmission by aerosols. |
format | Online Article Text |
id | pubmed-7876484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78764842021-02-11 Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 Steinhauer, K. Meister, T.L. Todt, D. Krawczyk, A. Paßvogel, L. Becker, B. Paulmann, D. Bischoff, B. Pfaender, S. Brill, F.H.H. Steinmann, E. J Hosp Infect Short Report The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commercially available antiseptic mouthwashes based on the active ingredients chlorhexidine digluconate and octenidine dihydrochloride (OCT) were investigated regarding their efficacy against SARS-CoV-2 using the European Standard 14476. Based on the requirement of EN 14476 in which reduction of at least four decimal logarithms (≥4 log(10)) of viral titre is requested to state efficacy, the OCT-based formulation was found to be effective within a contact time of only 15 s against SARS-CoV-2. Based on this in-vitro data the OCT mouthwash thus constitutes an interesting candidate for future clinical studies to prove its effectiveness in a potential prevention of SARS-CoV-2 transmission by aerosols. The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2021-05 2021-02-11 /pmc/articles/PMC7876484/ /pubmed/33582201 http://dx.doi.org/10.1016/j.jhin.2021.01.031 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Report Steinhauer, K. Meister, T.L. Todt, D. Krawczyk, A. Paßvogel, L. Becker, B. Paulmann, D. Bischoff, B. Pfaender, S. Brill, F.H.H. Steinmann, E. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 |
title | Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 |
title_full | Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 |
title_fullStr | Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 |
title_full_unstemmed | Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 |
title_short | Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 |
title_sort | comparison of the in-vitro efficacy of different mouthwash solutions targeting sars-cov-2 based on the european standard en 14476 |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876484/ https://www.ncbi.nlm.nih.gov/pubmed/33582201 http://dx.doi.org/10.1016/j.jhin.2021.01.031 |
work_keys_str_mv | AT steinhauerk comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT meistertl comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT todtd comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT krawczyka comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT paßvogell comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT beckerb comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT paulmannd comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT bischoffb comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT pfaenders comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT brillfhh comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 AT steinmanne comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476 |